These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37248764)

  • 21. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 23. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.
    Ren X; Wang X; Yan Y; Chen X; Cai Y; Liang Q; Peng B; Xu Z; He Q; Kang F; Li J; Zhang W; Hong Q; Peng J; Xiao M
    Aging (Albany NY); 2022 Jan; 14(2):961-974. PubMed ID: 35077390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
    Li Y; Wu D; Wei C; Yang X; Zhou S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 27. High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer.
    Li S; Huang J; Qin M; Zhang J; Liao C
    Mol Med Rep; 2020 Jul; 22(1):57-66. PubMed ID: 32319649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma.
    Bai Y; Lu D; Qu D; Li Y; Zhao N; Cui G; Li X; Sun X; Liu Y; Wei M; Yang Y
    Dis Markers; 2022; 2022():1844352. PubMed ID: 35692877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
    Liu S; Wang Y; Miao C; Xing Q; Wang Z
    Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.
    Tu J; Chen J; He M; Tong H; Liu H; Zhou B; Liao Y; Wang Z
    Onco Targets Ther; 2019; 12():5153-5162. PubMed ID: 31303768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential biomarkers for diagnosis of hepatocellular carcinoma.
    Liang XH; Feng ZP; Liu FQ; Yan R; Yin LY; Shen H; Lu HL
    Exp Ther Med; 2022 Jan; 23(1):51. PubMed ID: 34917180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of TPM1-4 in hepatocellular carcinoma.
    Tian Z; Zhao J; Wang Y
    Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation.
    Wan W; Shen Y; Li Q
    Cancer Manag Res; 2020; 12():9609-9619. PubMed ID: 33116820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma.
    Wu B; Huang Y; Luo Y; Ma A; Wu Z; Gan Y; Xu Y; Xu R
    J Cancer; 2020; 11(19):5727-5737. PubMed ID: 32913466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.